688131 Stock Overview
Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Shanghai Haoyuan Chemexpress Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥29.80 |
| 52 Week High | CN¥89.16 |
| 52 Week Low | CN¥26.00 |
| Beta | 0.33 |
| 1 Month Change | -27.05% |
| 3 Month Change | -29.63% |
| 1 Year Change | -65.29% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -81.36% |
Recent News & Updates
Shareholder Returns
| 688131 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | -8.9% | -4.4% | -0.4% |
| 1Y | -65.3% | -45.0% | -17.6% |
Return vs Industry: 688131 underperformed the CN Life Sciences industry which returned -45.5% over the past year.
Return vs Market: 688131 underperformed the CN Market which returned -17.8% over the past year.
Price Volatility
| 688131 volatility | |
|---|---|
| 688131 Average Weekly Movement | 10.0% |
| Life Sciences Industry Average Movement | 9.5% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 688131's share price has been volatile over the past 3 months.
Volatility Over Time: 688131's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 3,526 | Baofu Zheng | www.chemexpress.cn |
Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. It offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.
Shanghai Haoyuan Chemexpress Co., Ltd. Fundamentals Summary
| 688131 fundamental statistics | |
|---|---|
| Market cap | CN¥4.48b |
| Earnings (TTM) | CN¥121.13m |
| Revenue (TTM) | CN¥1.88b |
37.0x
P/E Ratio2.4x
P/S RatioIs 688131 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688131 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.88b |
| Cost of Revenue | CN¥0 |
| Gross Profit | CN¥1.88b |
| Other Expenses | CN¥1.76b |
| Earnings | CN¥121.13m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 25, 2024
| Earnings per share (EPS) | 0.81 |
| Gross Margin | 100.00% |
| Net Profit Margin | 6.45% |
| Debt/Equity Ratio | 41.7% |
How did 688131 perform over the long term?
See historical performance and comparison